What is Parkinson's Phase 3 Study CoQ10 QE3?

Category: Others

false

See also: Clinical Trial

NCT00740714 is a a clinical trial of the effects of Coenzyme Q10 with vitamin E in Parkinson Disease. Other study IDs includes: U01NS050324, QE3.

Purpose
Patients
Patients with evaluations
Perceived effectiveness
Patients
Patients with evaluations

  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects of Parkinson's Phase 3 Study CoQ10 QE3

Severe
0
Moderate
0
Mild
0
None
1

Dosages

Why Patients Stopped Using Parkinson's Phase 3 Study CoQ10 QE3 (multiple reasons could be selected)
Reason
Other
Patients
1
See all 1 patient who’ve stopped using Parkinson's Phase 3 Study CoQ10 QE3

Duration

Stopped Using Parkinson's Phase 3 Study CoQ10 QE3
Duration
Patients
Duration
0-1 month
Patients
0
Duration
1-3 months
Patients
0
Duration
3-6 months
Patients
0
Duration
6 months-1 year
Patients
0
Duration
1-2 years
Patients
1
Duration
2 years or more
Patients
0

Adherence


Always
Patients
0
0%
Usually
Patients
1
100%
Sometimes
Patients
0
0%
Never
Patients
0
0%

Burden


Very
Patients
0
0%
Somewhat
Patients
0
0%
A little
Patients
0
0%
Not at all
Patients
1
100%

Cost per month


Cost per month
$200+
Patients
0
0%
Cost per month
$100-199
Patients
0
0%
Cost per month
$50-99
Patients
0
0%
Cost per month
$25-49
Patients
0
0%
Cost per month
< $25
Patients
0
0%
Cost per month
Not specified
Patients
1
100%
Last updated:
There are no evaluations for Parkinson's Phase 3 Study CoQ10 QE3.